Cardiology 16% Flashcards
Inotropes
Ex:
MOA:
Ex: dobutamine, dopamine, epinephrine, digoxin
MOA: increase CO by increasing contractility
Chronotropes
Ex:
MOA:
Positive: adrenaline
Negative: digoxin
MOA: alter heart rate
Pressors
Ex:
MOA:
Ex: Dopamine, phenylephrine
MOA: improve pressure by increasing vascular tone
Postural hypotension =
> 20 mmHg drop in SBP OR >10 mmHg drop in DBP b/w supine and sitting and/or standing
Metabolic syndrome =
3 or more of the following:
- Truncal obesity
- HDL < 40 (men) or <50 (women)
- Hypertriglyceridemia: >150
- Fasting glucose >110
- HTN
Blood pressure for: Normal = PreHTN = HTN stage 1 = HTN stage 2 =
Normal = <120/<80
PreHTN = 120-139/80-90
HTN stage 1 = 140-159/90-99
HTN stage 2 = >160/>100
Hypertensive urgency =
Hypertensive emergency =
Increased BP w/ NO apparent acute end-organ damage
> 220 mmHg SBP or >125 mmHg DBP w/ acute target end-organ damage
ECG of HTN may reveal ____
left ventricular hypertrophy = deep S waves in V1 + V2, tall R waves in V5 + V6
Goal blood pressure in HTN
140/90
Goal blood pressure in diabetes or CKD
130/80
HCTZ, Chlorthalidone =
MOA:
SE:
Diuretic
MOA: prevent kidney Na/water reabsorption at DISTAL DILUTING TUBULE
SE: HypoNa, HypoK
hyperuricemia, hyperglycemia –> caution in pts w/ DM and gout
HTN medication that should be used w/ caution in pts w/ DM and gout
HCTZ, Chlorthalidone
Furosemide, bumetanide =
MOA:
SE:
Loop diuretics
MOA: inhibit water transport across Loop of Henle –> increased extretion of water, Na, Cl, K
SE: HypoK/Na/Cl, Hypochloremic metabolic alkalosis, hyperglycemia
HTN medication CI in pts w/ sulfa allergies.
Loop diuretics: Furosemide, bumetanide
Spironolactone, Amiloride, Eplerenone =
MOA:
SE:
K+ sparing diuretics
MOA: inhibit aldosterone-mediated Na/H2O absorption
SE: HyperK, gynecomastia
HTN medication that causes gynecomastia
K+ sparing diuretics: Spironolactone, Amiloride, Eplerenone
Nifedipine, amlodipine =
MOA:
Indication:
Dihydropyridines CCB
MOA: potent vasodilators (no effect on cardiac contractility/conduction)
Ind: HTN, Angina, Raynaud’s
Verapamil, Diltiazem =
MOA:
Indication:
Non-dihydropyridines CCB
MOA: cardiac contractility and conduction, potent vasodilators, reduce vascular permeability
Ind: HTN w/ A fib, Angina, Raynaud’s
HTN medication that causes constipation
verapamil
Cardioselective beta blockers: (3)
Non-cardioselective beta blockers: (1)
Cardioselective beta blockers (beta-1) : Atenolol, metoprolol, esmolol
Non-cardioselective beta blockers (beta-1 & beta-2): Propranolol
T/F: Beta blockers are used as 1st line monotherapy in HTN.
False. Thiazide diuretics (HTCZ) are tx of choice as initial therapy in uncomplicated HTN.
CI of beta blockers:
2nd/3rd heart block, decompensated heart failure
Nonselective beta blockers CI in asthma/COPD –> may worsen peripheral vascular disease/Raynaud’s phenomenon
CI of CCB:
pts taking beta blockers, CHF, 2nd/3rd heart block
Drug of choice for pts w/ HTN and BPH
Indications:
SE:
alpha-1 blockers: Prazosin, Terazosin, Doxazosin
Increased HDL, decrease LDL, improves insulin sensitivity
SE: 1st dose syncope, NOT 1st line